From: In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45
No.
Peptide
Start-End
Length
HLA-2 Binding Allele
VaxiJen Score
IC50
1
DLYIKGTSANMRET
301–314
14
HLA-DRB1*04:01
1.104
55
2
DLYIKGTSANMRETP
301–315
15
1.091
56
3
TDLYIKGTSANMRET
300–314
1.0182
54